---
document_datetime: 2025-12-02 06:50:18
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/aerivio-spiromax.html
document_name: aerivio-spiromax.html
version: success
processing_time: 0.0904997
conversion_datetime: 2025-12-27 21:32:50.768303
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Aerivio Spiromax

[RSS](/en/individual-human-medicine.xml/66084)

##### Withdrawn

This medicine's authorisation has been withdrawn

salmeterol / fluticasone propionate Medicine Human Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Aerivio Spiromax](#news-on)
- [Related content](#related-content-611)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 4 October 2019, the European Commission withdrew the marketing authorisation for Aerivio Spiromax (salmeterol / fluticasone propionate) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Teva B.V., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Aerivio Spiromax was granted marketing authorisation in the EU on 18 August 2016 for treatment of asthma and COPD.

The European Public Assessment Report (EPAR) for Aerivio Spiromax is updated to indicate that the marketing authorisation is no longer valid.

## Product information

Aerivio Spiromax : EPAR - Product Information

English (EN) (706.56 KB - PDF)

**First published:** 02/09/2016

**Last updated:** 15/01/2020

[View](/en/documents/product-information/aerivio-spiromax-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-49)

български (BG) (1.14 MB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/bg/documents/product-information/aerivio-spiromax-epar-product-information_bg.pdf)

español (ES) (779.86 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/es/documents/product-information/aerivio-spiromax-epar-product-information_es.pdf)

čeština (CS) (1.06 MB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/cs/documents/product-information/aerivio-spiromax-epar-product-information_cs.pdf)

dansk (DA) (700.27 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/da/documents/product-information/aerivio-spiromax-epar-product-information_da.pdf)

Deutsch (DE) (820.33 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/de/documents/product-information/aerivio-spiromax-epar-product-information_de.pdf)

eesti keel (ET) (887.03 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/et/documents/product-information/aerivio-spiromax-epar-product-information_et.pdf)

ελληνικά (EL) (1.02 MB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/el/documents/product-information/aerivio-spiromax-epar-product-information_el.pdf)

français (FR) (1.02 MB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/fr/documents/product-information/aerivio-spiromax-epar-product-information_fr.pdf)

hrvatski (HR) (839.65 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/hr/documents/product-information/aerivio-spiromax-epar-product-information_hr.pdf)

íslenska (IS) (790.81 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/is/documents/product-information/aerivio-spiromax-epar-product-information_is.pdf)

italiano (IT) (930.88 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/it/documents/product-information/aerivio-spiromax-epar-product-information_it.pdf)

latviešu valoda (LV) (1.03 MB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/lv/documents/product-information/aerivio-spiromax-epar-product-information_lv.pdf)

lietuvių kalba (LT) (821.66 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/lt/documents/product-information/aerivio-spiromax-epar-product-information_lt.pdf)

magyar (HU) (965.01 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/hu/documents/product-information/aerivio-spiromax-epar-product-information_hu.pdf)

Malti (MT) (1.1 MB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/mt/documents/product-information/aerivio-spiromax-epar-product-information_mt.pdf)

Nederlands (NL) (800.46 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/nl/documents/product-information/aerivio-spiromax-epar-product-information_nl.pdf)

norsk (NO) (713.9 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/no/documents/product-information/aerivio-spiromax-epar-product-information_no.pdf)

polski (PL) (933.29 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/pl/documents/product-information/aerivio-spiromax-epar-product-information_pl.pdf)

português (PT) (689.88 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/pt/documents/product-information/aerivio-spiromax-epar-product-information_pt.pdf)

română (RO) (912.85 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/ro/documents/product-information/aerivio-spiromax-epar-product-information_ro.pdf)

slovenčina (SK) (980.84 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/sk/documents/product-information/aerivio-spiromax-epar-product-information_sk.pdf)

slovenščina (SL) (988.47 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/sl/documents/product-information/aerivio-spiromax-epar-product-information_sl.pdf)

Suomi (FI) (617.34 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/fi/documents/product-information/aerivio-spiromax-epar-product-information_fi.pdf)

svenska (SV) (879.66 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/sv/documents/product-information/aerivio-spiromax-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IAIN/0003 04/10/2019

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Aerivio Spiromax : EPAR - All Authorised presentations

English (EN) (166.42 KB - PDF)

**First published:** 02/09/2016

**Last updated:** 15/01/2020

[View](/en/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-156)

български (BG) (195.67 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/bg/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_bg.pdf)

español (ES) (167.4 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/es/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_es.pdf)

čeština (CS) (187 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/cs/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (166.72 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/da/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (166.93 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/de/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (166.93 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/et/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (194.96 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/el/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_el.pdf)

français (FR) (167.27 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/fr/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (174.18 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/hr/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (166.93 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/is/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_is.pdf)

italiano (IT) (167.15 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/it/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (190.31 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/lv/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (182.58 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/lt/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (179.73 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/hu/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (190.32 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/mt/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (166.9 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/nl/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (166.99 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/no/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_no.pdf)

polski (PL) (181.11 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/pl/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_pl.pdf)

português (PT) (167.62 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/pt/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_pt.pdf)

română (RO) (174.72 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/ro/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (189.29 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/sk/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (179.2 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/sl/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (166.65 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/fi/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (167.18 KB - PDF)

**First published:**

02/09/2016

**Last updated:**

15/01/2020

[View](/sv/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Aerivio Spiromax Active substance

- salmeterol xinafoate
- fluticasone propionate

International non-proprietary name (INN) or common name

- salmeterol
- fluticasone propionate

Therapeutic area (MeSH)

- Pulmonary Disease, Chronic Obstructive
- Asthma

Anatomical therapeutic chemical (ATC) code R03AK06

### Pharmacotherapeutic group

Drugs for obstructive airway diseases

### Therapeutic indication

Aerivio Spiromax is indicated for use in adults aged 18 years and older only.

**Asthma**

Aerivio Spiromax is indicated for the regular treatment of patients with severe asthma where use of a combination product (inhaled corticosteroid and long-acting ?2 agonist) is appropriate:

- patients not adequately controlled on a lower strength corticosteroid combination product or
- patients already controlled on a high dose inhaled corticosteroid and long-acting ?2 agonist.

**Chronic Obstructive Pulmonary Disease (COPD)**

Aerivio Spiromax is indicated for the symptomatic treatment of patients with COPD, with a FEV1 &lt;60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy.

## Authorisation details

EMA product number EMEA/H/C/002752 Marketing authorisation holder

Teva B.V.

Swensweg 5

Opinion adopted 23/06/2016 Marketing authorisation issued 18/08/2016 Withdrawal of marketing authorisation 04/10/2019 Revision 2

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Aerivio Spiromax : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (219.88 KB - PDF)

**First published:** 10/04/2017

**Last updated:** 15/01/2020

[View](/en/documents/procedural-steps-after/aerivio-spiromax-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Aerivio Spiromax : EPAR - Public assessment report

Adopted

Reference Number: EMA/486136/2016

English (EN) (872.23 KB - PDF)

**First published:** 02/09/2016

**Last updated:** 15/01/2020

[View](/en/documents/assessment-report/aerivio-spiromax-epar-public-assessment-report_en.pdf)

CHMP summary of opinion for Aerivio Spiromax

Adopted

Reference Number: EMA/CHMP/431214/2016

English (EN) (230.8 KB - PDF)

**First published:** 24/06/2016

**Last updated:** 15/01/2020

[View](/en/documents/smop-initial/chmp-summary-opinion-aerivio-spiromax_en.pdf)

#### News on Aerivio Spiromax

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 June 2016](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-june-2016) 24/06/2016

#### Related content

- [Clinical data](https://clinicaldata.ema.europa.eu/web/cdp/home?p_p_id=cdpdossierviewportlet_WAR_cdpdossierviewportlet=0=maximized=view=column-3=2=EMEAHC0027520000) (initial marketing authorisation)

**This page was last updated on** 15/01/2020

## Share this page

[Back to top](#main-content)